Article
Novel Molecular Markers in Glioblastoma—Benefits of Liquid Biopsy
12 Oct 2020
Abstract excerpt
Glioblastoma is a primary Central Nervous System (CNS) malignancy with poor survival. Treatment options are scarce and despite the extremely heterogeneous nature of the disease, clinicians lack prognostic and predictive markers to characterize patients with different outcomes. Certain immunohistochemistry, FISH, or PCR-based molecular markers, including isocitrate dehydrogenase1/2 (IDH1/2) mutations, epidermal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
